Cargando…
Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer
SIMPLE SUMMARY: Breast cancer (BC) treatment relies on the detection of the estrogen receptor α (ERα). ERα-expressing BC patients are treated with anti-estrogen drugs (i.e., tamoxifen and fulvestrant). Despite their proven efficacy, these drugs cause serious side effects in a significant fraction of...
Autores principales: | Busonero, Claudia, Leone, Stefano, Bianchi, Fabrizio, Maspero, Elena, Fiocchetti, Marco, Palumbo, Orazio, Cipolletti, Manuela, Bartoloni, Stefania, Acconcia, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766733/ https://www.ncbi.nlm.nih.gov/pubmed/33352737 http://dx.doi.org/10.3390/cancers12123840 |
Ejemplares similares
-
A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells
por: Cipolletti, Manuela, et al.
Publicado: (2021) -
A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma
por: Cipolletti, Manuela, et al.
Publicado: (2023) -
The antiviral drug telaprevir induces cell death by reducing
FOXA1
expression in estrogen receptor α (ERα)‐positive breast cancer cells
por: Bartoloni, Stefania, et al.
Publicado: (2022) -
Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells
por: Pescatori, Sara, et al.
Publicado: (2022) -
The Peculiar Estrogenicity of Diethyl Phthalate: Modulation of Estrogen Receptor α Activities in the Proliferation of Breast Cancer Cells
por: Fiocchetti, Marco, et al.
Publicado: (2021)